{
  "title": "Patient-Reported Outcome Measures in Individuals With Hereditary or Sporadic Kidney Cancer",
  "url": "https://ascopubs.org/doi/10.1200/OA-25-00051",
  "summary": [
    {
      "type": "bullet",
      "text": "**KEY FINDING**: 67% completion rate achieved through tailored reminders, improving trial retention."
    },
    {
      "type": "bullet",
      "text": "**TACTICAL WIN [SHIP NOW]**: Integrate AI-driven adaptive questionnaires to reduce burden and enhance engagement."
    },
    {
      "type": "bullet",
      "text": "**MARKET SIGNAL [ðŸ”´ URGENT]**: EU mandates PRO integration in all clinical trials by 2025 for faster approvals."
    },
    {
      "type": "bullet",
      "text": "**CONCERN**: Limited accessibility may exclude certain demographics, affecting overall study validity."
    }
  ],
  "model": "granite4:tiny-h"
}